Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiovascular risk test

Author's Avatar
Apr 12, 2022

SomaScan® platform study utilizing 32,000 samples showed a 27-protein test is a uniquely superior surrogate for cardiovascular outcomes